Prothena (0Y3M) Stock Statistics & Valuation Metrics
Total Valuation
Prothena has a market cap or net worth of $434.82M. The enterprise value is $229.30M.
- Market Cap
- $434.82M
- Enterprise Value
- $229.30M
Share Statistics
Prothena has 51,336,975 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 51,336,975
- Owned by Insiders
- 5.63%
- Owned by Institutions
- 31.56%
Financial Efficiency
Prothena’s return on equity (ROE) is -0.87 and return on invested capital (ROIC) is -63.90%.
- Return on Equity (ROE)
- -0.87
- Return on Assets (ROA)
- -0.75
- Return on Invested Capital (ROIC)
- -63.90%
- Return on Capital Employed (ROCE)
- -0.65
- Revenue Per Employee
- 144.54K
- Profits Per Employee
- -3.64M
- Employee Count
- 67
- Asset Turnover
- 0.03
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Prothena is -10.20. Prothena’s PEG ratio is -0.05.
- PE Ratio
- -10.20
- PS Ratio
- 7.97
- PB Ratio
- 1.54
- Price to FCF
- -7.16
- Price to Operating Cash Flow
- -7.36
- PEG Ratio
- -0.05
Income Statement
In the last 12 months, Prothena had revenue of 9.68M and earned -244.09M in profits. Earnings per share was -4.53.
- Revenue
- 9.68M
- Gross Profit
- 5.98M
- Operating Income
- -184.56M
- Pretax Income
- -200.83M
- Net Income
- -244.09M
- EBITDA
- -199.93M
- Earnings Per Share (EPS)
- -4.53
Cash Flow
In the last 12 months, operating cash flow was -60.05M and capital expenditures -662,000, giving a free cash flow of -60.71M billion.
- Operating Cash Flow
- -60.05M
- Free Cash Flow
- -60.71M
- Free Cash Flow per Share
- -1.16
Dividends & Yields
Prothena pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -13.96%
- Earnings Yield
- -9.96%
Stock Price Statistics
- Beta
- 0.16
- 52-Week Price Change
- -19.13%
- 50-Day Moving Average
- 8.78
- 200-Day Moving Average
- 9.23
- Relative Strength Index (RSI)
- 49.17
- Average Volume (3m)
- 909
Important Dates
Prothena upcoming earnings date is Nov 05, 2026, After Close (Not Confirmed).
- Last Earnings Date
- Aug 06, 2026
- Next Earnings Date
- Nov 05, 2026
- Ex-Dividend Date
- ―
Financial Position
Prothena as a current ratio of 7.72, with Debt / Equity ratio of 4.94%
- Current Ratio
- 7.72
- Quick Ratio
- 7.72
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 1.47
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Prothena has paid 43.26M in taxes.
- Income Tax
- 43.26M
- Effective Tax Rate
- -0.22
Enterprise Valuation
Prothena EV to EBITDA ratio is -3.59, with an EV/FCF ratio of -2.53.
- EV to Sales
- 2.82
- EV to EBITDA
- -3.59
- EV to Free Cash Flow
- -2.53
- EV to Operating Cash Flow
- -2.56
Balance Sheet
Prothena has $288.19M in cash and marketable securities with $6.99M in debt, giving a net cash position of $281.20M billion.
- Cash & Marketable Securities
- $288.19M
- Total Debt
- $6.99M
- Net Cash
- $281.20M
- Net Cash Per Share
- $5.48
- Tangible Book Value Per Share
- $5.50
Margins
Gross margin is 43.52%, with operating margin of -115.09%, and net profit margin of -80.67%.
- Gross Margin
- 43.52%
- Operating Margin
- -115.09%
- Pretax Margin
- -79.97%
- Net Profit Margin
- -80.67%
- EBITDA Margin
- -78.45%
- EBIT Margin
- -79.97%
Analyst Forecast
The average price target for Prothena is $26.33, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- $26.33
- Price Target Upside
- 209.37% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 4
- Revenue Growth Forecast
- 427.32%
- EPS Growth Forecast
- 85.31%
Scores
- Smart Score
- 5
- AI Score
- ―